• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘和慢性阻塞性肺疾病中的白细胞介素-26

IL-26 in asthma and COPD.

作者信息

Cardenas Eduardo I, Che Karlhans Fru, Konradsen Jon R, Bao Aihua, Lindén Anders

机构信息

Division of Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.

Division of Clinical Immunology and Allergy, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.

出版信息

Expert Rev Respir Med. 2022 Mar;16(3):293-301. doi: 10.1080/17476348.2022.2045197. Epub 2022 Mar 2.

DOI:10.1080/17476348.2022.2045197
PMID:35188435
Abstract

INTRODUCTION

New targets are needed to enable more accurate diagnosis, monitoring and effective therapy in uncontrolled asthma and chronic obstructive pulmonary disease (COPD), two disorders characterized by pathogenic alterations in the innate immune response. Interestingly, the IL-10-related cytokine IL-26 has been found to be abundantly expressed in human airways and alterations in its expression have been linked to reduced lung function and markers of neutrophilic inflammation in patients with uncontrolled asthma or COPD.

AREAS COVERED

Literature search was conducted on PubMed to identify articles in the field of IL-26 immunology, as well as clinical studies on IL-26 in asthma and COPD, published between 2000 and 2021. We outline the main sources of IL-26 in human airways, as well as the effect of this cytokine on relevant immune and structural cells. Finally, we discuss the potential involvement of IL-26 in the pathophysiology of uncontrolled asthma and COPD.

EXPERT OPINION

IL-26 constitutes a potential target for diagnostic purposes and therapeutic modulation of the innate immune response in the airways of patients with asthma and COPD. It seems reasonable to expect more conclusive evidence of its clinical utility for personalized medicine within the coming 5-year period.

摘要

引言

在未控制的哮喘和慢性阻塞性肺疾病(COPD)中,需要新的靶点来实现更准确的诊断、监测和有效治疗,这两种疾病的特征是固有免疫反应发生致病性改变。有趣的是,已发现白细胞介素10相关细胞因子白细胞介素26(IL-26)在人类气道中大量表达,其表达改变与未控制的哮喘或COPD患者的肺功能降低及中性粒细胞炎症标志物有关。

涵盖领域

在PubMed上进行文献检索,以识别2000年至2021年间发表的关于IL-26免疫学领域的文章以及关于哮喘和COPD中IL-26的临床研究。我们概述了人类气道中IL-26的主要来源,以及这种细胞因子对相关免疫和结构细胞的影响。最后,我们讨论了IL-26在未控制的哮喘和COPD病理生理学中的潜在作用。

专家观点

IL-26构成了哮喘和COPD患者气道固有免疫反应诊断和治疗调节的潜在靶点。预计在未来5年内会有更多关于其在个性化医疗中临床效用的确凿证据,这似乎是合理的。

相似文献

1
IL-26 in asthma and COPD.哮喘和慢性阻塞性肺疾病中的白细胞介素-26
Expert Rev Respir Med. 2022 Mar;16(3):293-301. doi: 10.1080/17476348.2022.2045197. Epub 2022 Mar 2.
2
Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases.针对白细胞介素-17A/糖皮质激素协同作用靶向中性粒细胞气道疾病中的 CSF3 表达。
JCI Insight. 2020 Feb 13;5(3):132836. doi: 10.1172/jci.insight.132836.
3
Role of Neutrophil Extracellular Traps in Asthma and Chronic Obstructive Pulmonary Disease.中性粒细胞胞外诱捕网在哮喘和慢性阻塞性肺疾病中的作用
Chin Med J (Engl). 2017 Mar 20;130(6):730-736. doi: 10.4103/0366-6999.201608.
4
Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.轻至中度哮喘和慢性阻塞性肺疾病表型中的嗜酸性粒细胞性和中性粒细胞性气道炎症
COPD. 2017 Apr;14(2):181-189. doi: 10.1080/15412555.2016.1260539. Epub 2016 Dec 16.
5
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病患者痰液中炎症介质的分析。
Respiration. 2012;83(1):36-44. doi: 10.1159/000330667. Epub 2011 Sep 7.
6
Agents against cytokine synthesis or receptors.针对细胞因子合成或受体的药物。
Eur J Pharmacol. 2006 Mar 8;533(1-3):289-301. doi: 10.1016/j.ejphar.2005.12.046. Epub 2006 Feb 2.
7
Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.Th17 相关细胞因子 IL-17A 和 IL-17F 在哮喘和 COPD 中的表达。
Chest. 2010 Nov;138(5):1140-7. doi: 10.1378/chest.09-3058. Epub 2010 Jun 10.
8
Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations.Th17 细胞因子:COPD 发病机制和加重的新潜在治疗靶点。
Eur Respir J. 2017 Oct 12;50(4). doi: 10.1183/13993003.02434-2016. Print 2017 Oct.
9
The role of IL-2 cytokine family in asthma.白细胞介素-2 细胞因子家族在哮喘中的作用。
Cytokine. 2024 Aug;180:156638. doi: 10.1016/j.cyto.2024.156638. Epub 2024 May 17.
10
[The changes and significance of interleukin-17 in rat models of chronic obstructive pulmonary disease and asthma].[白细胞介素-17在慢性阻塞性肺疾病和哮喘大鼠模型中的变化及意义]
Zhonghua Jie He He Hu Xi Za Zhi. 2004 Oct;27(10):654-8.

引用本文的文献

1
The Association of Toll-like Receptor-9 Gene Single-Nucleotide Polymorphism and Serum Levels with Chronic Obstructive Pulmonary Disease Exacerbation Risk: A Case-Controlled Study with Bioinformatics Analysis.Toll样受体9基因单核苷酸多态性及血清水平与慢性阻塞性肺疾病急性加重风险的关联:一项生物信息学分析的病例对照研究
Biomedicines. 2025 Mar 3;13(3):613. doi: 10.3390/biomedicines13030613.
2
Systemic increase in IL-26 is associated with severe COVID-19 and comorbid obstructive lung disease.IL-26 的全身性增加与严重的 COVID-19 和合并阻塞性肺部疾病有关。
Front Immunol. 2024 Oct 4;15:1434186. doi: 10.3389/fimmu.2024.1434186. eCollection 2024.
3
Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
系统性白细胞介素-26 与对狗过敏原过敏的儿童哮喘控制改善相关。
Respir Res. 2024 Apr 15;25(1):163. doi: 10.1186/s12931-024-02773-7.
4
Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19.在急性 COVID-19 患者中,IL-26 水平升高与炎症过度激活和组织损伤的标志物相关。
Front Immunol. 2022 Nov 17;13:1016991. doi: 10.3389/fimmu.2022.1016991. eCollection 2022.
5
IL-26 in the Lung and Its Role in COPD Inflammation.肺部的白细胞介素-26及其在慢性阻塞性肺疾病炎症中的作用。
J Pers Med. 2022 Oct 9;12(10):1685. doi: 10.3390/jpm12101685.